Global Computed Tomography Devices Market
Marktgröße in Milliarden USD
CAGR : %
Prognosezeitraum |
2024 –2031 |
Marktgröße (Basisjahr) | USD 6.89 Billion |
Marktgröße (Prognosejahr) | USD 11.62 Billion |
CAGR |
|
Wichtige Marktteilnehmer |
|
Global Computed Tomography Devices Market, By Product Type (High-end Slice CT, Mid-end Slice CT, Low-end Slice CT, and Cone Beam CT (CBCT)), Application (Cardiovascular Applications, Abdomen and Pelvic Application, Pulmonary Angiogram, Neurovascular Application, Spinal Application, Musculoskeletal Application, and Oncology), End-User (Hospitals, Diagnostics and Centers) – Industry Trends and Forecast to 2031.
Computed Tomography Devices Market Analysis and Size
The computed tomography devices market is advancing with innovations such as spectral imaging, enhancing tissue differentiation and reducing radiation exposure. AI integration improves diagnostic accuracy, while portable CT scanners expand access in remote areas. Market growth is driven by rising chronic disease prevalence and technological upgrades, ensuring faster scans and improved patient outcomes globally.
The global computed tomography devices market size was valued at USD 6.89 billion in 2023 and is projected to reach USD 11.62 billion by 2031, with a CAGR of 6.76% during the forecast period 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
Report Metric |
Details |
Forecast Period |
2024 to 2031 |
Base Year |
2023 |
Historic Years |
2022 (Customizable to 2016-2021) |
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
Segments Covered |
Product Type (High-end Slice CT, Mid-end Slice CT, Low-end Slice CT, and Cone Beam CT (CBCT)), Application (Cardiovascular Applications, Abdomen and Pelvic Application, Pulmonary Angiogram, Neurovascular Application, Spinal Application, Musculoskeletal Application, and Oncology), End-User (Hospitals, Diagnostics and Centers) |
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
Market Players Covered |
GE HealthCare (U.S.), Siemens Healthcare Private Limited (Germany), Koninklijke Philips N.V. (Netherlands), Hitachi, Ltd. (Japan), Neusoft Corporation (China), Medtronic (Ireland), Shenzhen Anke High-tech Co., Ltd. (China), Accuray Incorporated (U.S.), PLANMED OY (Finland), Koning Health (U.S.), Carestream Health (U.S.), PointNix Co. Ltd (South Korea), Fujifilm Holdings Corporation (Japan), Hologic, Inc. (U.S.), and Shimadzu Corporation (Japan) |
Market Opportunities |
|
Market Definition
Computed tomography (CT) devices use X-ray technology to create detailed cross-sectional images of the body. These devices rotate around the patient, capturing multiple X-ray images from different angles. Advanced computer processing combines these images to generate detailed 3D representations of internal structures. CT scans are widely used in medical diagnostics for detecting abnormalities in organs, bones, and tissues with high precision.
Computed Tomography Devices Market Dynamics
Drivers
- Growing Demand for Point-of-Care Testing
The growing demand for point-of-care testing is transforming healthcare by fostering the adoption of portable and compact CT devices. These innovations enable rapid diagnostic imaging directly at the patient's bedside, crucial in emergency and critical care settings where immediate decisions are vital. For instance, portable CT scanners such as the CereTom have revolutionized neuroimaging by providing real-time diagnostic capabilities in intensive care units, enhancing patient management and outcomes with timely interventions.
- Rising Chronic Disease Burden
The increasing prevalence of chronic diseases such as cardiovascular disorders, cancer, and neurological conditions is driving the demand for CT scans. For instance, in oncology, CT scans are crucial for early detection, accurate staging, and monitoring treatment responses. Similarly, in cardiovascular care, CT angiography plays a vital role in diagnosing and managing heart disease. This growing demand underscores the pivotal role of CT devices in improving patient outcomes and fueling market growth.
Opportunities
- Advancements in Software and Data Management
Advancements in software for CT imaging, including enhanced image reconstruction and robust data management solutions, create opportunities by seamlessly integrating with electronic health records (EHRs) and telemedicine platforms. For instance, streamlined data sharing between healthcare providers improves collaboration and diagnostic efficiency. This integration not only enhances patient care by enabling remote consultations but also expands market reach by meeting the growing demand for efficient and interconnected healthcare solutions globally.
- Integration with Artificial Intelligence (AI) and Machine Learning
Integration of AI and machine learning in CT devices creates opportunities by significantly improving diagnostic capabilities. AI algorithms analyze CT images for anomalies with high accuracy, aiding in early disease detection and precise treatment planning. For instance, AI-powered software can differentiate between benign and malignant lesions in lung CT scans, reducing diagnostic errors and improving patient outcomes. This enhances the appeal of CT devices across medical specialties, driving market growth and adoption.
Restraints/Challenges
- High Cost of Equipment
The high cost of CT scanners poses a significant barrier for healthcare facilities, particularly in developing regions or smaller hospitals with constrained budgets. These expenses encompass purchasing, maintenance, and operational costs, limiting accessibility and adoption of CT technology. This financial burden hinders market expansion, restricting widespread availability of advanced diagnostic capabilities in healthcare settings worldwide.
- Data Privacy and Security Concerns
Data privacy and security concerns surrounding CT scans, which generate vast amounts of sensitive patient data, present significant challenges for manufacturers and healthcare providers. Ensuring compliance with stringent data protection regulations and maintaining robust cybersecurity measures are imperative but can hinder market growth due to increased operational complexities and potential risks of data breaches.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In February 2024, Koning Health achieved regulatory clearance from the Federal Authority for Nuclear Regulation (FANR) in the UAE. This milestone establishes Koning as the foremost provider of breast CT technology in the region, revolutionizing breast imaging and healthcare standards
- In January 2024, GE HealthCare acquired MIM Software, renowned for AI-driven solutions in medical imaging analysis. Specializing in radiation oncology, molecular radiotherapy, and urology, MIM Software enhances digital workflows and analytics, reinforcing GE HealthCare's commitment to advancing patient care globally
- In January 2023, GE HealthCare finalized its acquisition of IMACTIS, a French company specializing in CT interventional guidance systems. This move bolsters GE HealthCare's capabilities in innovative healthcare solutions across diverse medical settings
- In November 2023, At the RSNA Congress, Canon Medical Systems Corp. unveiled updates to its CT portfolio, including the flagship Aquilion ONE / INSIGHT Edition and the high-throughput Aquilion Serve SP, enhancing diagnostic capabilities and throughput in radiology
Computed Tomography Devices Market Scope
The market is segmented on the basis product type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- High-end Slice CT
- Mid-end Slice CT
- Low-end Slice CT
- Cone Beam CT (CBCT)
Application
- Cardiovascular Applications
- Abdomen and Pelvic Application
- Pulmonary Angiogram
- Neurovascular Application
- Spinal Application
- Musculoskeletal Application
- Oncology
End-User
- Hospitals
- Diagnostics
- Centers
Computed Tomography Devices Market Regional Analysis/Insights
The market is analysed and market size insights and trends are provided by country, product type, application and end-user as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is projected to dominate the computed tomography devices market due to its aging population, high prevalence of chronic diseases, patient preference for advanced technologies, and robust healthcare infrastructure. These factors drive demand for CT devices, ensuring North America maintains a leading position in this healthcare technology sector.
Asia-Pacific is expected to witness significant growth in the computed tomography devices market due to developing healthcare infrastructure, expanding economies such as India and China, high prevalence of chronic disorders, and the presence of major market players and suppliers in the region. These factors contribute to robust market expansion prospects during the forecast period.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Computed Tomography Devices Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- GE HealthCare (U.S.)
- Siemens Healthcare Private Limited (Germany)
- Koninklijke Philips N.V. (Netherlands)
- Hitachi, Ltd. (Japan)
- Neusoft Corporation (China)
- Medtronic (Ireland)
- Shenzhen Anke High-tech Co., Ltd. (China)
- Accuray Incorporated (U.S.)
- PLANMED OY (Finland)
- Koning Health (U.S.)
- Carestream Health (U.S.)
- PointNix Co. Ltd (South Korea)
- Fujifilm Holdings Corporation (Japan)
- Hologic, Inc. (U.S.)
- Shimadzu Corporation (Japan)
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.